Literature DB >> 33539012

The Connection Between Cell Fate and Telomere.

Ayse Basak Engin1, Atilla Engin2.   

Abstract

Abolition of telomerase activity results in telomere shortening, a process that eventually destabilizes the ends of chromosomes, leading to genomic instability and cell growth arrest or death. Telomere shortening leads to the attainment of the "Hayflick limit", and the transition of cells to state of senescence. If senescence is bypassed, cells undergo crisis through loss of checkpoints. This process causes massive cell death concomitant with further telomere shortening and spontaneous telomere fusions. In functional telomere of mammalian cells, DNA contains double-stranded tandem repeats of TTAGGG. The Shelterin complex, which is composed of six different proteins, is required for the regulation of telomere length and stability in cells. Telomere protection by telomeric repeat binding protein 2 (TRF2) is dependent on DNA damage response (DDR) inhibition via formation of T-loop structures. Many protein kinases contribute to the DDR activated cell cycle checkpoint pathways, and prevent DNA replication until damaged DNA is repaired. Thereby, the connection between cell fate and telomere length-associated telomerase activity is regulated by multiple protein kinase activities. Contrarily, inactivation of DNA damage checkpoint protein kinases in senescent cells can restore cell-cycle progression into S phase. Therefore, telomere-initiated senescence is a DNA damage checkpoint response that is activated with a direct contribution from dysfunctional telomeres. In this review, in addition to the above mentioned, the choice of main repair pathways, which comprise non-homologous end joining and homologous recombination in telomere uncapping telomere dysfunctions, are discussed.

Entities:  

Keywords:  Ataxia- and Rad3-related (ATR); Ataxia-telangiectasia mutated (ATM); DNA damage response (DDR); DNA double-strand breaks (DSBs); Hayflick limit; Homologous recombination (HR); Homology directed repair (HDR); Human telomeric reverse transcriptase (hTERT); Nonhomologous end joining (NHEJ); Shelterin complex; T-loop; Telomerase; Telomere; telomeric repeat binding factor 2 (TRF2)

Mesh:

Substances:

Year:  2021        PMID: 33539012     DOI: 10.1007/978-3-030-49844-3_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  235 in total

1.  Extensive allelic variation and ultrashort telomeres in senescent human cells.

Authors:  Duncan M Baird; Jan Rowson; David Wynford-Thomas; David Kipling
Journal:  Nat Genet       Date:  2003-01-21       Impact factor: 38.330

Review 2.  Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.

Authors:  Manasi S Apte; Julia Promisel Cooper
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-11-28       Impact factor: 8.250

Review 3.  Cellular functions of the dual-targeted catalytic subunit of telomerase, telomerase reverse transcriptase--potential role in senescence and aging.

Authors:  Niloofar Ale-Agha; Nadine Dyballa-Rukes; Sascha Jakob; Joachim Altschmied; Judith Haendeler
Journal:  Exp Gerontol       Date:  2014-02-28       Impact factor: 4.032

Review 4.  Chk1 and Chk2 kinases in checkpoint control and cancer.

Authors:  Jiri Bartek; Jiri Lukas
Journal:  Cancer Cell       Date:  2003-05       Impact factor: 31.743

Review 5.  Molecular and biological hallmarks of ageing.

Authors:  J R Aunan; M M Watson; H R Hagland; K Søreide
Journal:  Br J Surg       Date:  2016-01       Impact factor: 6.939

6.  MAPK pathway activation delays G2/M progression by destabilizing Cdc25B.

Authors:  Puji Astuti; Tanya Pike; Charlotte Widberg; Elizabeth Payne; Angus Harding; John Hancock; Brian Gabrielli
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

7.  Chemokine signaling via the CXCR2 receptor reinforces senescence.

Authors:  Juan C Acosta; Ana O'Loghlen; Ana Banito; Maria V Guijarro; Arnaud Augert; Selina Raguz; Marzia Fumagalli; Marco Da Costa; Celia Brown; Nikolay Popov; Yoshihiro Takatsu; Jonathan Melamed; Fabrizio d'Adda di Fagagna; David Bernard; Eva Hernando; Jesús Gil
Journal:  Cell       Date:  2008-06-13       Impact factor: 41.582

8.  Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN.

Authors:  Nausica Arnoult; Adriana Correia; Jiao Ma; Anna Merlo; Sara Garcia-Gomez; Marija Maric; Marco Tognetti; Christopher W Benner; Simon J Boulton; Alan Saghatelian; Jan Karlseder
Journal:  Nature       Date:  2017-09-20       Impact factor: 49.962

9.  A complex secretory program orchestrated by the inflammasome controls paracrine senescence.

Authors:  Juan Carlos Acosta; Ana Banito; Torsten Wuestefeld; Athena Georgilis; Peggy Janich; Jennifer P Morton; Dimitris Athineos; Tae-Won Kang; Felix Lasitschka; Mindaugas Andrulis; Gloria Pascual; Kelly J Morris; Sadaf Khan; Hong Jin; Gopuraja Dharmalingam; Ambrosius P Snijders; Thomas Carroll; David Capper; Catrin Pritchard; Gareth J Inman; Thomas Longerich; Owen J Sansom; Salvador Aznar Benitah; Lars Zender; Jesús Gil
Journal:  Nat Cell Biol       Date:  2013-06-16       Impact factor: 28.824

10.  NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.

Authors:  Kiyohiro Ando; Toshinori Ozaki; Toru Hirota; Akira Nakagawara
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more
  1 in total

Review 1.  Mitochondrial Fus1/Tusc2 and cellular Ca2+ homeostasis: tumor suppressor, anti-inflammatory and anti-aging implications.

Authors:  Roman Uzhachenko; Akiko Shimamoto; Sanika S Chirwa; Sergey V Ivanov; Alla V Ivanova; Anil Shanker
Journal:  Cancer Gene Ther       Date:  2022-02-18       Impact factor: 5.854

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.